Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21176949 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Primary Rituximab and Maintenance
Condition: Follicular Lymphoma
Interventions: Drug: Rituximab;   Drug: rituximab

Indicates status has not been verified in more than two years